Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema

Published:2014-02-03 Issue:7 Volume:16 Page:1006-1009
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Carlson J. A.,Nooruddin Z.,Rusthoven C.,Elias A.,Borges V. F.,Diamond J. R.,Kavanagh B.,Kabos P.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/16/7/1006/6910931/not329.pdf

Reference27 articles.

1. HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues

2. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

3. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

4. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

5. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery;Radiotherapy and Oncology;2024-10

2. Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates;Critical Reviews in Oncology/Hematology;2024-03

3. Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature;Frontiers in Oncology;2024-01-10

4. The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors;Journal of Hematology & Oncology;2024-01-04

5. Combining radiation and systemic therapy;Palliative Radiation Oncology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3